Sree Rayalaseema Hi-Strength Hypo Ltd
NSE: SRHHYPOLTD BSE: 532842
Incorporated in 2005, Sree Rayalaseema Hi – Strength Hypo Ltd is a producer of producer of Calcium Hypo -chloride, Stable Bleaching Powder, Sulphuric Acid and other chemicals[1]
₹497
52W: ₹381 — ₹717
PE 8.29 · Book ₹588 · -15% vs bookMarket Cap₹854 Cr
Stock P/E8.29Price to Earnings
ROCE14.9%Return on Capital
ROE11%Return on Equity
Div. Yield0.6%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Stock is trading at 0.83 times its book value
Weaknesses
- −The company has delivered a poor sales growth of -1.53% over past five years.
- −Earnings include an other income of Rs.41.2 Cr.
- −Dividend payout has been low at 5.47% of profits over last 3 years
- −Debtor days have increased from 45.7 to 59.1 days.
Shareholding Pattern
Promoters61.84%
FIIs0.07%
DIIs0.05%
Public38.05%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.84% | 61.84% | 61.84% | 61.84% | 61.84% | 61.84% | 61.84% | 61.84% |
| FIIs | 0.55% | 0.14%▼0.4 | 0.08%▼0.1 | 0.14%▲0.1 | 0.12%▼0.0 | 0.06%▼0.1 | 0.06% | 0.07%▲0.0 |
| DIIs | 0.04% | 0.04% | 0.04% | 0.05%▲0.0 | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 37.57% | 37.99%▲0.4 | 38.04%▲0.0 | 37.98%▼0.1 | 38%▲0.0 | 38.05%▲0.0 | 38.05% | 38.05% |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 226 | 215 | 165 | 169 | 170 | 138 | 160 | 180 | 182 | 141 |
| Expenses | 199 | 192 | 138 | 142 | 140 | 117 | 143 | 152 | 155 | 121 |
| Operating Profit | 26 | 22 | 27 | 27 | 30 | 21 | 18 | 28 | 27 | 20 |
| OPM % | 12% | 10% | 16% | 16% | 18% | 15% | 11% | 16% | 15% | 14% |
| Net Profit | 18 | 17 | 21 | 20 | 26 | 24 | 23 | 23 | 24 | 24 |
| EPS ₹ | 10.78 | 9.69 | 12.22 | 11.94 | 15.12 | 13.71 | 13.23 | 13.64 | 14.2 | 14.16 |
AI Insights
Revenue Trend
TTM revenue at ₹664Cr, up 4.1% YoY. OPM at 14%.
Debt Position
Borrowings at ₹13Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.
Institutional Flow
DIIs: 0.05% (+0.01pp change). FIIs: 0.07% (-0.53pp change). Promoters hold 61.84%.
Margin & Efficiency
ROCE improving from 11% (Mar 2014) to 15% (Mar 2025). Working capital days: 79.
Valuation
PE 8.29x with 14.9% ROCE. Price is -15% above book value of ₹588. Dividend yield: 0.6%.
Recent Announcements
- Board Meeting Intimation for Approval Of Audited Financial Results For Quarter / Year Ending 31St March,2026 And Recommendation Of Final Dividend If Any, For Year Ending 31St March,2026. 14 May - Board meeting on May 30, 2026 to approve FY26 audited results and consider final dividend.
- Submission Of Report On Special Window 14 Apr - March 2026 special-window re-lodgement report filed; 1 request, average processing 2 days.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Submitted Regulation 74(5) dematerialization certificate for quarter ended March 31, 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Apr - Submission of newspaper publications with regard to special window and second saksham Niveshak
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 4 Apr - April 2, 2026: Company confirms it is not a large corporate; outstanding borrowings nil.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse